It was proven that the peripheral trafficking of CXCR4+/CD34+/CD133+ VSELs was increased in gastric cancer 20 and pancreatic cancer 21, suggesting that CXCR4 may participate in the formation of gastrointestinal cancer. This evidence concerns the gene CXCR4 and familial pancreatic carcinoma.